Insider: Reardon Andrew CLO & Secretary - LIGAND PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 44,620 | 0 | 44,620 |
| Value | $8,905,705.80 | $0.00 | $8,905,705.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/01/2026 | DDS | 1,302 | Direct | COM | $199.72 | $260,038.17 | 44,620 |
| 04/01/2026 | DDS | 337 | Direct | COM | $204.50 | $68,917.38 | 41,382 |
| 04/01/2026 | DDS | 1,238 | Direct | COM | $200.94 | $248,767.31 | 43,382 |
| 04/01/2026 | DDS | 460 | Direct | COM | $198.85 | $91,470.68 | 45,922 |
| 04/01/2026 | DDS | 700 | Direct | COM | $201.90 | $141,327.97 | 42,682 |
| 04/01/2026 | DDS | 963 | Direct | COM | $203.22 | $195,702.59 | 41,719 |
| 03/04/2026 | DDS | 93 | Direct | COM | $200.62 | $18,657.89 | 41,369 |
| 03/04/2026 | DDS | 300 | Direct | COM | $201.70 | $60,510.00 | 41,069 |
| 03/04/2026 | DDS | 100 | Direct | COM | $199.01 | $19,900.50 | 41,669 |
| 03/04/2026 | DDS | 100 | Direct | COM | $197.70 | $19,769.54 | 41,769 |
| 03/04/2026 | DDS | 207 | Direct | COM | $199.96 | $41,390.89 | 41,462 |
| 03/04/2026 | DDS | 200 | Direct | COM | $204.17 | $40,834.00 | 40,869 |
| 03/04/2026 | DDS | 1,142 | Direct | COM | $208.87 | $238,532.28 | 36,869 |
| 03/04/2026 | DDS | 1,446 | Direct | COM | $208.12 | $300,939.06 | 38,011 |
| 03/04/2026 | DDS | 612 | Direct | COM | $207.01 | $126,689.45 | 39,457 |
| 03/04/2026 | DDS | 340 | Direct | COM | $206.37 | $70,164.78 | 40,069 |
| 03/04/2026 | DDS | 460 | Direct | COM | $205.18 | $94,381.88 | 40,409 |
| 06/23/2025 | DDS | 500 | Direct | COM | $114.08 | $57,042.15 | 31,903 |
| 06/10/2025 | DDS | 500 | Direct | COM | $114.54 | $57,270.70 | 32,403 |
| 05/15/2025 | DDS | 1,000 | Direct | COM | $104.00 | $104,000.00 | 32,903 |
| 09/23/2024 | DDS | 2,000 | Direct | COM | $99.60 | $199,201.00 | 22,534 |
| 08/28/2024 | DDS | 1,500 | Direct | COM | $106.39 | $159,590.55 | 22,534 |
| 05/09/2024 | DDS | 10,000 | Direct | COM | $83.04 | $830,449.00 | 22,205 |
| 03/24/2023 | DDS | 300 | Direct | COM | $69.92 | $20,977.29 | 16,308 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research